Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
BIOJECT MEDICAL TECHNOLOGIES INC (BJCT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/27/2015 |
8-K
| Quarterly results |
| 08/14/2015 |
8-K
| Quarterly results |
| 05/15/2015 |
8-K
| Quarterly results |
| 11/12/2014 |
8-K
| Quarterly results |
| 08/15/2014 |
8-K
| Quarterly results|
Docs:
|
"Form of Note from Bioject to the Mark A. Logomasini & Associates, Inc. SEP Fund in the principal amount of $100,000",
"For value received,",
"SECURITY AGREEMENT This Security Agreement is made June 25, 2014 by and among Bioject Medical Technologies Inc. and its wholly owned subsidiary Bioject Inc. , each an Oregon corporation, and each with offices at, 7180 SW Sandburg Street, Tigard, Oregon 97223 , and Mark A. Logomasini & Associates, Inc. SEP Fund and Amir Ness, the holders of the Company's Senior Secured Bridge Promissory Notes in the amounts of $100,000 and $50,000, respectively, dated June 23, 2014 and June 25, 2014, respectively and with the addresses set forth on the signature page hereto . RECITALS The Noteholders have agreed to make a secured loan to the Company, evidenced by the Notes, are secured by all the accounts receivable from Ferring Pharmaceuticals to the Company, whether presently existing or hereafter acquire...",
"BIOJECT REPORTS UNAUDITED SECOND QUARTER 2014 FINANCIAL RESULTS" |
|
| 05/15/2014 |
8-K
| Quarterly results |
| 11/08/2011 |
8-K
| Form 8-K - Current report |
| 08/10/2011 |
8-K
| Quarterly results|
Docs:
|
"BIOJECT REPORTS SECOND QUARTER 2011 FINANCIAL RESULTS Revenue Doubles Over Second Quarter 2010 PORTLAND, OR, August 10, 2011 - Bioject Medical Technologies Inc. , a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ended June 30, 2011. Bioject reported revenues of $2.4 million for the quarter ended June 30, 2011, compared to revenues of $1.2 million in the comparable 2010 period. Product sales were $2.2 million in the 2011 period compared to $1.0 million in the comparable 2010 period. License and technology fees were $209,000 for the quarter ended June 30, 2011, compared to $117,000 in the comparable 2010 period. The Company reported operating income of $276,000 in the second quarter of 2011 compared to an operating loss of $593..." |
|
| 05/11/2011 |
8-K
| Quarterly results|
Docs:
|
"BIOJECT REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS Revenues increase 47% over first quarter 2010 PORTLAND, OR - May 11, 2011 - Bioject Medical Technologies Inc. , a leading developer of needle-free drug delivery systems, today reported financial results for the quarter ended March 31, 2011. For the quarter ended March 31, 2011, Bioject reported revenues of $1.7 million compared to $1.2 million in the comparable year-ago quarter. Product sales for the first quarter of 2011 were $1.6 million compared to $1.1 million in the year-ago quarter. License and technology fees for the first quarter of 2011 were $122,000, compared to $96,000 in the comparable year ago period. Operating expenses for the first quarter of 2011 were $1.9 million compared to $1.7 million in the first quarter of 2010. The..." |
|
| 11/10/2010 |
8-K
| Form 8-K - Current report |
| 08/04/2010 |
8-K
| Form 8-K - Current report |
| 11/05/2009 |
8-K
| Form 8-K - Current report |
| 08/06/2009 |
8-K
| Quarterly results|
Docs:
|
"BIOJECT REPORTS SECOND-QUARTER 2009 FINANCIAL RESULTS Operating loss declines 86% and net loss allocable to common shareholders decreases by 68% over second quarter 2008 results PORTLAND, OR, August 5, 2009 - Bioject Medical Technologies Inc. , a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ended June 30, 2009. Bioject reported revenues of $1.7 million for the quarter ended June 30, 2009, unchanged from the comparable 2008 period. Product sales were $1.6 million in the 2009 period compared to $1.4 million in the comparable 2008 period. License and technology fees were $124,000 for the quarter ended June 30, 2009 compared to $275,000 in the comparable 2008 period. The Company reported an operating loss of $108,000 in the sec..." |
|
| 05/07/2009 |
8-K
| Quarterly results |
| 11/10/2008 |
8-K
| Quarterly results|
Docs:
|
"BIOJECT REPORTS THIRD-QUARTER 2008 RESULTS PORTLAND, OR, November 10, 2008 - Bioject Medical Technologies Inc. , a leading developer of needle-free injection therapy systems, today announced financial results for the third quarter of 2008. For the third quarter of 2008, Bioject reported revenues of $1.7 million, compared to $1.8 million reported in the comparable year ago quarter. Third-quarter 2008 product sales were $1.5 million compared to $1.7 million in the third quarter of the prior year. License and technology fees for the third quarter of 2008 were $139,000, compared to $83,000 in the year-ago quarter. Operating expenses for the third quarter of 2008 were $2.2 million, compared to $2.7 million in the comparable 2007 third quarter, a 19% decrease from the year ago period. The Compan..." |
|
| 08/07/2008 |
8-K
| Quarterly results|
Docs:
|
"BIOJECT REPORTS SECOND-QUARTER 2008 FINANCIAL RESULTS PORTLAND, OR, August 6, 2008 - Bioject Medical Technologies Inc. , a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ended June 30, 2008. Bioject reported revenues of $1.7 million for the quarter ended June 30, 2008, compared to revenues of $2.8 million in the comparable 2007 period. Product sales were $1.4 million in the 2008 period compared to $2.0 million in the comparable 2007 period. License and technology fees were $275,000 for the quarter ended June 30, 2008 compared to $802,000 in the comparable 2007 period. The Company reported an operating loss of $787,000 in the second quarter of 2008 compared to an operating loss of $296,000 in the second quarter of 2007. Includ..." |
|
| 05/08/2008 |
8-K
| Quarterly results |
| 11/01/2007 |
8-K
| Quarterly results |
| 08/09/2007 |
8-K
| Quarterly results |
| 05/10/2007 |
8-K
| Quarterly results |
| 11/02/2006 |
8-K
| Quarterly results |
|
|